Cargando…

427. Putting the ‘Eye’ in Spirochetes

BACKGROUND: Ocular syphilis is an infrequent presentation of Treponema pallidum infection. It is often seen in association with neurosyphilis but can occur in isolation as well. Here we describe a case series of 10 patients with ocular syphilis seen at our institution. METHODS: Patients with a diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Sarwat, Fida, Madiha, Challener, Douglas W, Tan, Eugene, Sohail, Muhammad R, Abu Saleh, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809560/
http://dx.doi.org/10.1093/ofid/ofz360.500
_version_ 1783462018416640000
author Khalil, Sarwat
Fida, Madiha
Challener, Douglas W
Tan, Eugene
Sohail, Muhammad R
Abu Saleh, Omar
author_facet Khalil, Sarwat
Fida, Madiha
Challener, Douglas W
Tan, Eugene
Sohail, Muhammad R
Abu Saleh, Omar
author_sort Khalil, Sarwat
collection PubMed
description BACKGROUND: Ocular syphilis is an infrequent presentation of Treponema pallidum infection. It is often seen in association with neurosyphilis but can occur in isolation as well. Here we describe a case series of 10 patients with ocular syphilis seen at our institution. METHODS: Patients with a diagnosis of ocular syphilis at the three sites of Mayo Clinic were identified from June 2006 to February 2019. Patient’s baseline characteristics, clinical presentation, diagnostic testing, and treatment were abstracted from Electronic Medical Records. RESULTS: We identified 10 patients (17 eyes) during the study period, half being diagnosed in the last 5 years. The median age was 51 years (IQR 21–66), and the majority were males (7/10). Characteristics of the patients are outlined in Table 1. Common presenting symptoms included vision loss (8/10), photophobia (4/10), and irritation (5/10). Seven of 10 patients had bilateral involvement. Of the 17 eyes, 59% had pan-uveitis and 82% had disc edema (Table 2). Rapid Plasma Reagin (RPR) was positive in 9 patients and median serum RPR was 1:128 (IQR 1:2-1:1024). One patient was diagnosed with a positive TP-PA, and characteristic ocular findings. One patients had positive 16S Ribosomal RNA Gene PCR/Sanger Sequencing on vitreous humor specimen for Treponema species. The majority of patients had isolated ocular symptoms at presentation; two patients also had an associated skin rash. All patients underwent a lumbar puncture (LP). Half had pleocytosis (TNC > 5) and elevated protein elevated (mean 63.6 mg/dL), although not significantly high. 3/10 patients had VDRL positive in the CSF. Protein levels were much higher in those with positive VDRL. Each patient was treated with intravenous (IV) penicillin for at least 2 weeks. Nine patients received ocular steroids as well. At last available follow-up, 8 had complete and 1 had partial resolution. One had worsened eye findings with eventual scarring. CONCLUSION: Our findings are congruent with increasing incidence of ocular syphilis nationwide. Bilateral eye involvement and pan-uveitis were the most common ocular findings. Although only 3 patients had a positive VDRL in the CSF, pleocytosis and elevated protein were found in a large number of patients. Majority of the patients had clinical resolution with appropriate treatment. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809560
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68095602019-10-28 427. Putting the ‘Eye’ in Spirochetes Khalil, Sarwat Fida, Madiha Challener, Douglas W Tan, Eugene Sohail, Muhammad R Abu Saleh, Omar Open Forum Infect Dis Abstracts BACKGROUND: Ocular syphilis is an infrequent presentation of Treponema pallidum infection. It is often seen in association with neurosyphilis but can occur in isolation as well. Here we describe a case series of 10 patients with ocular syphilis seen at our institution. METHODS: Patients with a diagnosis of ocular syphilis at the three sites of Mayo Clinic were identified from June 2006 to February 2019. Patient’s baseline characteristics, clinical presentation, diagnostic testing, and treatment were abstracted from Electronic Medical Records. RESULTS: We identified 10 patients (17 eyes) during the study period, half being diagnosed in the last 5 years. The median age was 51 years (IQR 21–66), and the majority were males (7/10). Characteristics of the patients are outlined in Table 1. Common presenting symptoms included vision loss (8/10), photophobia (4/10), and irritation (5/10). Seven of 10 patients had bilateral involvement. Of the 17 eyes, 59% had pan-uveitis and 82% had disc edema (Table 2). Rapid Plasma Reagin (RPR) was positive in 9 patients and median serum RPR was 1:128 (IQR 1:2-1:1024). One patient was diagnosed with a positive TP-PA, and characteristic ocular findings. One patients had positive 16S Ribosomal RNA Gene PCR/Sanger Sequencing on vitreous humor specimen for Treponema species. The majority of patients had isolated ocular symptoms at presentation; two patients also had an associated skin rash. All patients underwent a lumbar puncture (LP). Half had pleocytosis (TNC > 5) and elevated protein elevated (mean 63.6 mg/dL), although not significantly high. 3/10 patients had VDRL positive in the CSF. Protein levels were much higher in those with positive VDRL. Each patient was treated with intravenous (IV) penicillin for at least 2 weeks. Nine patients received ocular steroids as well. At last available follow-up, 8 had complete and 1 had partial resolution. One had worsened eye findings with eventual scarring. CONCLUSION: Our findings are congruent with increasing incidence of ocular syphilis nationwide. Bilateral eye involvement and pan-uveitis were the most common ocular findings. Although only 3 patients had a positive VDRL in the CSF, pleocytosis and elevated protein were found in a large number of patients. Majority of the patients had clinical resolution with appropriate treatment. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809560/ http://dx.doi.org/10.1093/ofid/ofz360.500 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Khalil, Sarwat
Fida, Madiha
Challener, Douglas W
Tan, Eugene
Sohail, Muhammad R
Abu Saleh, Omar
427. Putting the ‘Eye’ in Spirochetes
title 427. Putting the ‘Eye’ in Spirochetes
title_full 427. Putting the ‘Eye’ in Spirochetes
title_fullStr 427. Putting the ‘Eye’ in Spirochetes
title_full_unstemmed 427. Putting the ‘Eye’ in Spirochetes
title_short 427. Putting the ‘Eye’ in Spirochetes
title_sort 427. putting the ‘eye’ in spirochetes
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809560/
http://dx.doi.org/10.1093/ofid/ofz360.500
work_keys_str_mv AT khalilsarwat 427puttingtheeyeinspirochetes
AT fidamadiha 427puttingtheeyeinspirochetes
AT challenerdouglasw 427puttingtheeyeinspirochetes
AT taneugene 427puttingtheeyeinspirochetes
AT sohailmuhammadr 427puttingtheeyeinspirochetes
AT abusalehomar 427puttingtheeyeinspirochetes